Predictors of recurrence and disease-free survival for salivary gland tumors among children and young adults in Kampala, Uganda: a retrospective follow-up study

Author:

Vuhahula Edda A. M.,Yahaya James J.,Ngaiza Advera I.,Morgan Emmanuel D.,Abraham Zephania S.

Abstract

Abstract Background Salivary gland tumors are a group of tumors which are highly heterogeneous, and they are uncommon among children and young adults. We aimed to investigate the predictors of recurrence and disease-free survival for salivary gland tumors among children and young adults. Methods We retrospectively extracted clinical, pathologic, and follow-up data of patients who were diagnosed histologically with salivary gland tumors from January 2013 to December 2018 at the department of pathology, Makerere University in Kampala, Uganda. Then, we applied Cox regression analysis to determine the predictors of disease-free survival using hazard ratio as the measure of probability of the survival with 95% confidence interval. We also used Kaplan–Meier curves to analyze the disease-free survival. P ˂ 0.05 was considered significant. Results A total of 144 patients with salivary gland tumors were included in the present study who were aged not more than 20 years with mean age of 13.9 ± 4.5 years. Over one quarter (26.4%, n = 38) of the salivary gland tumors that were analyzed in the present study were malignant. The prevalence of recurrence was (27.1%, n = 39), and the mean disease-free survival was 58.7 ± 1.9 months. Category of the salivary gland (AHR = 1.36, 95% CI = 0.137–0.942, p = 0.037) and behavior of the tumors (AHR = 1.82, 95% CI = 0.729–0.990, p = 0.023) were the potential predictors of disease-free survival. Conclusion Over one quarter of the patients had malignant salivary tumors, and also, one-third of the patients developed recurrence at the end of the follow-up period of 6 years. Involvement of minor salivary glands and having a malignant salivary gland tumor both have shown increased risk of recurrence as well as short disease-free survival. Therefore, patients with minor salivary gland involvement and those with malignant variants require optimal surgical resection of the tumors for possible prevention of early recurrence and increasing the survival of the patients without relapse of such tumors after initial resection of the primary lesions.

Publisher

Springer Science and Business Media LLC

Subject

Otorhinolaryngology

Reference50 articles.

1. Di Villeneuve L, Souza IL, Tolentino FDS, Ferrarotto R, Schvartsman G (2020) Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease. Front Oncol 10(October):1–12

2. Namboodiripad PCA (2014) A review: immunological markers for malignant salivary gland tumors. J Oral Biol Craniofacial Res. 4(2):127–134. https://doi.org/10.1016/j.jobcr.2014.05.003

3. Jensen JS, Grønhøj C, Garset-Zamani M, Westergaard-Nielsen M, Bjørndal K, Kiss K et al (2021) Incidence and survival of salivary gland cancer in children and young adults in Denmark: a nation-wide study for the period 1990–2015. Int J Pediatr Otorhinolaryngol 143(January):1–5

4. Chen AM, Garcia J, Granchi PJ, Johnson J, Eisele DW (2008) Late recurrence from salivary gland cancer: when does “cure” mean cure? Cancer 112(2):340–344

5. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW (1989) Carcinoma of major salivary glands: recent trends. Arch Otolaryngol Neck Surg 115(3):316–321

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3